Summary
McKesson Corporation's 2011 Form 10-K filing highlights its position as a leading healthcare services and information technology company. The report indicates a robust market capitalization, with the aggregate market value of common equity held by non-affiliates exceeding $15.5 billion as of September 2010. This signifies substantial investor confidence and the company's significant presence in the market. The filing structure suggests a comprehensive review of its business operations, risk factors, legal proceedings, financial performance, and corporate governance.
Financial Highlights
58 data pointsBeta
Financial Statements
Beta
| Revenue | $112.08B |
| Cost of Revenue | $106.11B |
| Gross Profit | $5.97B |
| R&D Expenses | $407.00M |
| Operating Expenses | $4.15B |
| Operating Income | $1.82B |
| Net Income | $1.20B |
| EPS (Basic) | $4.65 |
| EPS (Diluted) | $4.57 |
| Shares Outstanding (Basic) | 258.00M |
| Shares Outstanding (Diluted) | 263.00M |
Key Highlights
- 1McKesson Corporation is a large accelerated filer, indicating a well-established company with significant public float and trading volume.
- 2The aggregate market value of common equity held by non-affiliates was approximately $15.5 billion as of September 2010, underscoring its substantial market capitalization.
- 3As of April 29, 2011, McKesson had over 252 million shares of common stock outstanding.
- 4The report structure signifies a thorough examination of the company's business (Part I), financial performance and condition (Part II), and governance (Part III).
- 5The incorporation by reference of portions of the 2011 Proxy Statement into Part III suggests that key information regarding directors, executive compensation, and security ownership will be readily available to investors.
- 6The filing explicitly addresses key areas such as Risk Factors, Legal Proceedings, and Management's Discussion and Analysis of Financial Condition and Results of Operations, providing crucial insights for investor due diligence.
Frequently Asked Questions
While the full details are within the referenced sections, the filing structure indicates McKesson is a major player in healthcare services and information technology, with business operations, financial performance, and corporate governance being key areas of focus.
The aggregate market value of common equity held by non-affiliates was approximately $15.5 billion in September 2010, suggesting a strong market valuation and significant investor interest in the company.
Detailed financial performance and operational insights can be found in Part II, specifically within Item 6 (Selected Financial Data) and Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations).
Information regarding McKesson's Directors, Executive Officers, Corporate Governance, Executive Compensation, and Security Ownership is detailed in Part III of the Form 10-K filing, with further details incorporated by reference from the 2011 Proxy Statement.